New genetics platform and AI health assistant integrate directly into each member's care plan, connecting DNA, biomarkers, and clinical guidance in one ecosystem

PHOENIX: Geviti, an end-to-end preventative health and longevity platform, today announced two major additions to its already advanced AI interpretation of healthcare diagnostics. Geviti Genetics, a clinical-grade DNA test that integrates directly into each member's active care protocol, and Makor AI, a personalized health assistant grounded in each member's own bloodwork, care plan, supplements, and wearable data.

Together, these launches expand Geviti's testing suite beyond bloodwork and gut health to include genetics while giving members always-on access to an AI assistant built around their unique health profile. The additions address a common gap in consumer health: at-home DNA tests often leave patients to interpret complex results on their own, while general-purpose AI tools provide advice without the context of an individual's medical data or care plan.

"Your bloodwork shows where your health stands today. Your DNA helps explain how you got there, and essentially, where you're headed. Together, they provide a level of clinical insight that neither can deliver alone," said Nathan Graville, co-founder of Geviti. "Most genetic tests hand you a report and leave you to figure out what to do with it. Every gene in our panel connects to an actionable health decision that informs our healthcare team build each member's personalized healthcare blueprint."

Geviti Genetics includes analysis of more than 160 SNPs across 12 health categories, including cardiovascular risk, drug metabolism, detoxification pathways, cancer risk, hormonal pathways, methylation, and mental health. Rather than delivering a standalone genetic report, every result is integrated into each member's personalized care plan, allowing their Longevity Specialist to tailor nutrition, exercise, stress resilience, and supplementation recommendations based on their genetic profile. Testing is processed by Gene by Gene in Houston, Texas, a CLIA-certified laboratory operating under CAP/CLIA laboratory-developed test (LDT) standards. Test kits typically arrive within 3–5 business days, with results returned in approximately 10 business days.

In addition to Geviti Genetics, the company is also launching Makor AI, a personalized health assistant designed around each member's unique health profile rather than generalized internet data. Unlike traditional AI tools, Makor AI draws on a member's bloodwork, personalized care plan, supplements, connected wearable data, and Geviti's proprietary clinical knowledge base to provide contextual, easy-to-understand health guidance without sacrificing clinical depth.

Built using a human-in-the-loop model, Makor AI seamlessly connects members with Geviti's clinical care team whenever additional support is needed. Conversations carry forward with full context, allowing members to transition from AI guidance to their care team without repeating information or starting over.

"If you're relying on general AI for health advice, the answers aren't truly personalized to you, and that's the problem Makor AI was built to solve," said Elijah Fougnies, co-founder and Chief Brand Officer of Geviti. "General AI doesn't know your bloodwork, your genetics, your health history, or the care plan you've built with your clinical team. Your health is as unique as your fingerprint, and your AI should be too. Makor AI becomes an extension of your care team, answering the in-between questions instantly while reinforcing the personalized plan your Longevity Specialists have created for you."

Together, these launches mark another step in Geviti's mission to unify preventative healthcare by delivering personalized protocols and prescription therapeutics through one integrated ecosystem. Both offerings are now available in every state where Geviti currently operates.

About Geviti

Geviti is an end-to-end preventative health and longevity platform that combines comprehensive bloodwork, gut health testing, clinical-grade genetic testing, and AI-powered support into a single, integrated care experience. Founded by self-taught engineer Nathan Graville after losing his father to late-diagnosed stage 4 lung cancer, Geviti was built to make proactive, personalized healthcare more accessible. The company currently operates in 47 U.S. states, raised an $8.5 million seed round in May 2025, and is preparing for its Series A financing. Learn more at gogeviti.com.

Fonte: Business Wire